Format

Send to

Choose Destination
Oncotarget. 2018 Sep 18;9(73):33741-33742. doi: 10.18632/oncotarget.26052. eCollection 2018 Sep 18.

Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success.

Author information

1
Jordi Bruix: BCLC group, Liver Unit, Hospital ClĂ­nic de Barcelona, IDIBAPS, CIBERehd, Universitat de Barcelona, Barcelona, Spain.

KEYWORDS:

MET expression; hepatocellular carcinoma; outcome; systemic therapy; trial design

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center